Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

LUPIN

  • FDA Approval
  • Nov. 02, 2023, 11:46 UTC
  • 35
  • 0 comments

FDA approve CARVEDILOL

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Oct. 31, 2023, 18:37 UTC
  • 31
  • 0 comments

FDA approve EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Oct. 31, 2023, 18:30 UTC
  • 28
  • 0 comments

FDA approve EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Oct. 31, 2023, 17:18 UTC
  • 31
  • 0 comments

FDA approve PITAVASTATIN SODIUM

Comment Full text

ULTRAGENYX PHARM INC

  • FDA Approval
  • Oct. 31, 2023, 16:34 UTC
  • 30
  • 0 comments

FDA approve TRIHEPTANOIN

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Oct. 31, 2023, 11:38 UTC
  • 34
  • 0 comments

FDA approve DOXAZOSIN MESYLATE

Comment Full text

TORRENT

  • FDA Approval
  • Oct. 31, 2023, 11:38 UTC
  • 37
  • 0 comments

FDA approve NEBIVOLOL HYDROCHLORIDE

Comment Full text

AUROBINDO

  • FDA Approval
  • Oct. 31, 2023, 11:38 UTC
  • 36
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

ELI LILLY AND CO

  • FDA Approval
  • Oct. 30, 2023, 16:04 UTC
  • 32
  • 0 comments

FDA approve MIRIKIZUMAB-MRKZ

Comment Full text

PADAGIS US

  • FDA Approval
  • Oct. 30, 2023, 11:43 UTC
  • 34
  • 0 comments

FDA approve SCOPOLAMINE

Comment Full text
  • Previous
  • 640
  • 641
  • 642
  • 643
  • 644
  • Next

Search

News categories

  • Technical Exchange News(11967)
  • Event(5000)
  • SEC News(246674)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148719)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin